alirocumab
amatuximab
anifrolumab
anrukinzumab
bapineuzumab
basiliximab
bavituximab
bevacizumab
bimagrumab
bimekizumab
blosozumab
briakinumab
budigalimab
cabiralizumab
camrelizumab
carlumab
cemiplimab
cetrelimab
cetuximab
concizumab
crenezumab
crizanlizumab
dacetuzumab
denosumab
duligotuzumab
eculizumab
evinacumab
fasinumab
fletikumab
foralumab
fremanezumab
fulranumab
galiximab
gevokizumab
girentuximab
glembatumumab
golimumab
ianalumab
icrucumab
infliximab
isatuximab
ixekizumab
lampalizumab
lanadelumab
lebrikizumab
lexatumumab
lirilumab
lumiliximab
margetuximab
matuzumab
mavrilimumab
mirikizumab
mirvetuximab
mogamulizumab
muromonab
nesvacumab
nimotuzumab
nivolumab
obiltoxaximab
ocrelizumab
olokizumab
omalizumab
omburtamab
otlertuzumab
pamrevlumab
patritumab
pembrolizumab
plozalizumab
ponezumab
quilizumab
rontalizumab
rozanolixizumab
seribantumab
simtuzumab
sirukumab
solanezumab
spartalizumab
sutimlimab
tabalumab
tarextumab
tavolimab
tigatuzumab
toripalimab
tovetumab
tralokinumab
tregalizumab
ublituximab
urelumab
utomilumab
visilizumab
xentuzumab
